Goldman Sachs & Co. Form 8.1 - [Pfizer Inc.] (6280G)
23 November 2015 - 11:16PM
UK Regulatory
TIDMPFZ
RNS Number : 6280G
Goldman Sachs & Co.
23 November 2015
Ap9
APPENDIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL
ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1. KEY INFORMATION
Name of person dealing (GS) GOLDMAN, SACHS
(Note 1) & CO.
======================= ===================
Company dealt in PFIZER INC
======================= ===================
Class of relevant USD ordinary
security to which
the dealings being
disclosed relate
(Note 2)
======================= ===================
Date of dealing 20 November 2015
======================= ===================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
============================ ================== ===================
Number (%) Number (%)
============================ =========== ===== =========== ======
20,466,836 12,653,419
(1) Relevant securities (0.33) (0.20)
============================ ================== ===================
(2) Derivatives (other 4,006,465 3,821,485
than options) (0.06) (0.06)
============================ ================== ===================
(3) Options and agreements 10,961,762 29,211,400
to purchase/sell (0.17) (0.47)
============================ ================== ===================
35,435,063 45,686,304
Total (0.57) (0.74)
============================ ================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant Long Short
security:
============================= ==================== =====================
Number (%) Number (%)
============================= =========== ===== =========== ======
(1) Relevant securities
============================= ==================== =====================
(2) Derivatives (other
than options)
============================= ==================== =====================
(3) Options and agreements
to purchase/sell
============================= ==================== =====================
Total
============================= ==================== =====================
Ap10
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant Price per
securities unit (Note
5)
============== ========================= ================
Purchase 3,000 32.0850 USD
============== ========================= ================
Purchase 3,000 32.0850 USD
============== ========================= ================
Purchase 1,700 32.0850 USD
============== ========================= ================
Purchase 3,000 32.0850 USD
============== ========================= ================
Purchase 100 32.0900 USD
============== ========================= ================
Purchase 100 32.0900 USD
============== ========================= ================
Purchase 200 32.0900 USD
============== ========================= ================
Purchase 200 32.0900 USD
============== ========================= ================
Purchase 100 32.0900 USD
============== ========================= ================
Purchase 200 32.0900 USD
============== ========================= ================
Purchase 200 32.0900 USD
============== ========================= ================
Purchase 300 32.0900 USD
============== ========================= ================
Purchase 3,000 32.0950 USD
============== ========================= ================
Purchase 5,432 32.0950 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 900 32.1000 USD
============== ========================= ================
Purchase 300 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 300 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 869 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 200 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 331 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 200 32.1000 USD
============== ========================= ================
Purchase 100 32.1000 USD
============== ========================= ================
Purchase 500 32.1000 USD
============== ========================= ================
Purchase 140 32.1100 USD
============== ========================= ================
Purchase 105 32.1100 USD
============== ========================= ================
Purchase 400 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 200 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 200 32.1100 USD
============== ========================= ================
Purchase 195 32.1100 USD
============== ========================= ================
Purchase 5 32.1100 USD
============== ========================= ================
Purchase 160 32.1100 USD
============== ========================= ================
Purchase 300 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 300 32.1100 USD
============== ========================= ================
Purchase 300 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 15 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
============== ========================= ================
Purchase 100 32.1100 USD
(MORE TO FOLLOW) Dow Jones Newswires
November 23, 2015 07:16 ET (12:16 GMT)
Pfizer (LSE:PFZ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pfizer (LSE:PFZ)
Historical Stock Chart
From Nov 2023 to Nov 2024
